Bojana Turic, MD – Director, President & CEO
As CEO of PMI Labs, Dr. Turic's extensive experience andproven ability to lead will be instrumental in the expansion of service and continued commercialization of innovative technology for early cancer detection products. Prior to being appointed CEO, Dr. Turic served as Vice President and COO. As one of the senior scientists of PMI Labs when it was founded in 1999, she has led the Company through significant clinical and regulatory milestones including, positioning the company as a world leader in early cancer diagnostic technologies, the development of strategic commercialization alliances, and execution of the company’s first commercial agreements. Dr. Turic completed her MD at the University of Sarajevo, Bosnia and Herzegovina where she held the position of Assistant Professor of Medical Microbiology.